SEC Form 4 · accession 0001053369-15-000026
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas Plassche
Officer — Executive VP of Operations
Period of report
Apr 27, 2015
Accepted (ET)
Apr 28, 2015 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2015 | S | 85,530 | $0.2358 | D | 73,094 | D |
Table II — derivative securities
No Table II lines on this filing.